Skip to main content
SpringerLink
Log in

Erneute Stammzelltransplantation nach dem Rezidiv erfolgreich

Fortgeschrittenes multiples Myelom

  • neues aus der forschung
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Cook G et al. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(8):874–85.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Wolfgang Zimmermann

Authors
  1. Wolfgang Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zimmermann, W. Erneute Stammzelltransplantation nach dem Rezidiv erfolgreich. Info Onkol. 17, 27 (2014). https://doi.org/10.1007/s15004-014-0931-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-014-0931-x

Search

Navigation